Published in Medical Letter on the CDC and FDA, November 18th, 2001
Acambis PLC seems a somewhat unlikely partner for the U.S. Health Department at such a critical moment. It has lost money each year since its founding in 1993, and it has just 150 employees, two-thirds of them at a subsidiary in Cambridge, Massachusetts.
"They've been lucky that they've been in the right place at the right time," said Richard Parkes, a biotechnology analyst at investment bank ING Barings.
Acambis won a $343 million contract...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.